GeneLink: a database to facilitate genetic studies of complex traits by Gillanders, Elizabeth M et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
BMC Genomics
Open Access Software
GeneLink: a database to facilitate genetic studies of complex traits
Elizabeth M Gillanders1, Anthony Masiello2, Derek Gildea1, 
Lowell Umayam2, Priya Duggal3, Mary Pat Jones2, Alison P Klein3, 
Diana Freas-Lutz1, Grace Ibay3, Ken Trout2, Tyra G Wolfsberg2, 
Jeffrey M Trent4, Joan E Bailey-Wilson2 and Andreas D Baxevanis*2
Address: 1Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-8000, USA, 
2Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-8002, USA, 
3Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, MD 21224, USA and 
4Translational Genomics Research Institute, Phoenix, AZ 85004, USA
Email: Elizabeth M Gillanders - lgilland@mail.nih.gov; Anthony Masiello - ant@masiello.org; Derek Gildea - dgildea@mail.nih.gov; 
Lowell Umayam - umayamla@mail.nih.gov; Priya Duggal - pduggal@nhgri.nih.gov; Mary Pat Jones - mpjones@nhgri.nih.gov; 
Alison P Klein - aklein@nhgri.nih.gov; Diana Freas-Lutz - dlutz@nhgri.nih.gov; Grace Ibay - gibay@nhgri.nih.gov; 
Ken Trout - nezumi@fred.net; Tyra G Wolfsberg - tyra@nhgri.nih.gov; Jeffrey M Trent - jtrent@tgen.org; Joan E Bailey-
Wilson - jebw@mail.nih.gov; Andreas D Baxevanis* - andy@nhgri.nih.gov
* Corresponding author    
Abstract
Background: In contrast to gene-mapping studies of simple Mendelian disorders, genetic analyses
of complex traits are far more challenging, and high quality data management systems are often
critical to the success of these projects. To minimize the difficulties inherent in complex trait
studies, we have developed GeneLink, a Web-accessible, password-protected Sybase database.
Results: GeneLink is a powerful tool for complex trait mapping, enabling genotypic data to be
easily merged with pedigree and extensive phenotypic data. Specifically designed to facilitate large-
scale (multi-center) genetic linkage or association studies, GeneLink securely and efficiently handles
large amounts of data and provides additional features to facilitate data analysis by existing software
packages and quality control. These include the ability to download chromosome-specific data files
containing marker data in map order in various formats appropriate for downstream analyses (e.g.,
GAS and LINKAGE). Furthermore, an unlimited number of phenotypes (either qualitative or
quantitative) can be stored and analyzed. Finally, GeneLink generates several quality assurance
reports, including genotyping success rates of specified DNA samples or success and
heterozygosity rates for specified markers.
Conclusions: GeneLink has already proven an invaluable tool for complex trait mapping studies
and is discussed primarily in the context of our large, multi-center study of hereditary prostate
cancer (HPC). GeneLink is freely available at http://research.nhgri.nih.gov/genelink.
Background
In the past decade, hundreds of genes involved in the eti-
ology of simple Mendelian disorders such as cystic fibrosis
and Huntington's disease have been identified [1-3]. The
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genetic localization of these disorders, primarily through
positional cloning approaches, has been highly successful
because of the relatively simple model underlying disease
pathogenesis. In the majority of these cases, a single
mutated disease gene is both necessary and sufficient to
cause the observed trait. In contrast, susceptibility to com-
plex traits is heterogeneous, involving both multiple
genetic and environmental risk factors, acting either inde-
pendently or together.
Efforts to identify susceptibility genes involved in com-
plex traits such as cancer, diabetes, hypertension, or
Alzheimer's disease are complicated by genetic heteroge-
neity, incompplete penetrance, phenocopies, and the later
age of onset of disease (thus unavailable DNA samples for
parents of affected individuals). Each of these factors
results in a significant reduction in power for any given
study. Therefore, gene-mapping studies of complex traits
require high-throughput genotyping performed on large
collections of DNA samples using hundreds to thousands
of polymorphic markers. The significant amounts of data
generated during these genome surveys pose numerous
data management challenges. In order to address these
challenges, which are inherent in any large, collaborative
genotyping study, we have developed a robust, easy-to-
use database system named GeneLink.
GeneLink was initially developed to facilitate our studies
of genetic susceptibility to prostate cancer, whose aims are
to identify novel high- and moderate- penetrance genes
involved in hereditary prostate cancer risk. These studies
are multi-center collaborative efforts involving researchers
from the United States, Finland, and Sweden [4-7]. The
project included 496 families containing 5,247 individu-
als; DNA on 2,374 of these individuals was available for
genotyping. We genotyped over 400 microsatellite mark-
ers for these individuals generating close to one million
genotypes. This number is large but not atypical in gene
mapping studies of complex traits. Given the considerable
number of genotypes requiring analysis, it was obvious
that we needed to develop a database management system
that could handle such large quantities of data, as well as
address data management issues unique to complex trait
genetic analysis.
Implementation
GeneLink is a platform-independent, Web-accessible
Sybase database that can manage complete genotypic,
phenotypic and pedigree data for genetic linkage or asso-
ciation studies. Figure 1 shows the comprehensive
GeneLink user's menu available following login. Access to
the GeneLink database can be limited using two inde-
pendent mechanisms. First, users can be granted one or
more activity or privilege levels. The admin (administra-
tor) privilege provides a user the ability to view data as
well as manage access to the data. Users without admin
privileges can be assigned the following privileges by the
administrator: export, import, modify and view, with obvi-
ous permissions. Project- or user-specific reports summa-
rizing assigned privileges can be generated. Second, as
GeneLink provides the ability to associate a "group" (of
users) with a collection site-specific set of families, collab-
orators can be provided the ability to view and/or manip-
ulate all or only a subset of data.
Currently, GeneLink's database uses Sybase SQL server
ASE 12.5.1, which runs on a Sun V880 computer running
Unix. GeneLink's Web scripts to access the database
require Perl version 5.6.1 or greater. The necessary CPAN
Perl modules required by GeneLink are DBI,
DBD::Sybase, CGI, and Carp. These modules are usually
included in standard Perl 5 releases. A Web server such as
Apache 1.3.29 is also required to run the GeneLink Web
scripts. GeneLink can operate on a Sun Enterprise 6500 or
similar machine configured to operate as a Web server.
Database structure
Figure 2 shows the relational design of the GeneLink data-
base in detail. Data within GeneLink is stored in 11 pri-
mary tables: Families, Pedigrees, Trait Score, Traits
Translations, Markers, Primers, Maps, Genotypes,
Allele Translations, Liability Classes and  DNA.  Each
table can be populated either by importing multiple
records from a delimited text file or by inserting a single
record at a time through a Web interface. The Families
table stores pertinent clinical information regarding each
family as a whole; each record reflects a single family
included in the linkage or association study. For example,
in our HPC study, we used the Families table to store
information regarding evidence of male-to-male trans-
mission of disease as well as the occurrence of other can-
cer types in the family. The Pedigrees table stores one
record per individual within a family and contains the
biological relationships (FatherID,  MotherID) for each
individual. Also included in the Pedigrees table is age,
sex, whether the individual has been or will be genotyped
(Age, Sex, DNA), two ways to store qualitative phenotype
information (StatusBroad, StatusNarrow), and individual
liability class information. In our HPC study, we defined
prostate cancer affection status in two ways; specifically,
we used the StatusBroad  field to classify individuals as
affected, unaffected or unknown, while the StatusNarrow
definition was used for an affecteds-only analysis in which
individuals were coded either as affected or unknown.
More extensive trait or covariate information can also be
stored in the Trait Score table. This table stores an unlim-
ited number of qualitative or quantitative phenotypes as
trait 1, trait 2, trait 3, and so forth. Definitions of the traits
are stored in the Traits Translation table.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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The Markers table stores information regarding all mark-
ers typed in a given project, including the panel in which
the marker was run. A panel is defined as a group of mic-
rosatellite or SNP markers which can be electrophoresed
simultaneously by taking advantage of different fluores-
cent dye labels and varying amplicon sizes. Also stored in
the Markers table is the allele size range (ASR) of the
marker, the fluorescent dye used to label the forward
primer, and the marker-specific genotype for a CEPH con-
trol individual (e.g., CEPH 1347-02 was used in our pros-
tate cancer study). The Primers table provides additional
information for each specific marker. This information
includes UniSTS ID, GenBank accession number, forward
primer sequence, reverse primer sequence, and primer
purchasing and inventory information. The Primers table
also contains comprehensive genetic map information
(deCODE, Généthon, and Marshfield positions) as well as
physical location (Build, physical start position, and physical
stop position). The Maps table stores the genetic map loca-
tion of a marker in the genome, as well as the relative
order of markers along a chromosome and the distance
between adjacent markers. The markers typed thus far in
our HPC study are di-, tri-, or tetra- nucleotide repeats;
however GeneLink is capable of handling any combina-
tion of microsatellite and single nucleotide polymor-
phisms (SNP) data.
Main menu Figure 1
Main menu GeneLink's main menu available following login. GeneLink is a platform-independent, Web-accessible database. 
Access to GeneLink is password-protected. Here the user (lgilland) has been given import, export, view, and admin, permissions.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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The  Genotypes  table is where final genotype data are
stored. Each record represents an individual/marker com-
bination and alleles are stored as size in base pairs. The
Genotypes  table also holds information regarding the
laboratory run (Grid,  Lane). When exporting data in
LINKAGE or RelCheck format, GeneLink systematically
recodes genotype labels (1, 2, 3,...) to provide properly-
formatted data for analysis by these programs. The Allele
Translations table provides a key or legend linking the
newly "translated" genotype to the original size in base-
pairs score. Future exports use identical "allele translation
codes." New alleles identified after the first export will be
added to the end of a marker's allele translation ensuring
consistent recoding of alleles across exports (Figure 3).
The Liability Class table stores information regarding spe-
cific liability classes, which can be incorporated in each
LINKAGE export for analysis. Liability classes can cur-
rently be defined using any combination of age, sex, and
affection status (based on StatusBroad, or StatusNarrow
from the pedigrees table). For example, in our HPC study
we used five different liability classes (Figure 4). Specifi-
cally, we were able to assign older, unaffected men (more
likely not to be gene carriers) to a different liability class
than younger, unaffected men who may be gene carriers
but who have not yet presented with the disease. Finally,
the DNA table stores information regarding all available
DNA samples in the laboratory. This includes specifics
regarding date received, concentration, quantity, and stor-
age location.
Each of GeneLink's 11 tables has measures built-in for
quality control purposes. First, all changes (import, mod-
ification or delete) to GeneLink records are stamped with
the date, time, and USER ID of the individual doing the
Relational design Figure 2
Relational design Relational design of GeneLink's 11 primary tables. Primary keys are indicated in red and foreign keys in 
blue. GeneLink enables pedigree information stored in the Families and Pedigrees tables to be easily merged with genotypic 
data stored in the Genotypes table. In the Pedigrees, Liability Classes, Trait Score, and Trait Translation tables 
GeneLink also manages extensive phenotypic data. The Markers and Primer tables store information regarding polymor-
phisms being genotyped and the Maps table stores genetic or physical map information, which determines the order in which 
data is exported. GeneLink's Primer and DNA tables provide labs with an easily implemented inventory system.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
Page 5 of 14
(page number not for citation purposes)
editing. Changes to the families, pedigrees, or genotypes
tables can be easily reviewed in a Histories table. Second,
contents of every field are verified on import, and users
are warned of any failures, such as invalid format or dupli-
cate records. Within the Pedigrees  table specifically,
checks were designed to confirm the presence of all indi-
viduals designated as parents within the families, as well
as confirm that all fathers are male and all mothers are
female. In addition, when genotypes are imported into
the Genotypes table, GeneLink confirms that each indi-
vidual included in the import is designated as having
DNA in the Pedigrees table. Next, GeneLink checks that
Allele translation Figure 3
Allele translation The Allele Translations table provides a key linking the "translated" allele (Translation) to the original size in 
base-pairs score (Allele). All LINKAGE or RelCheck exports will use identical "allele translation codes." In this example, 15 alle-
les have been identified for marker D1S206. New alleles identified after the first export (in this example alleles 10 to 15) will be 
added to the end of a marker's allele translation ensuring consistent recoding of alleles across families.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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each allele falls within the marker's designated allele size
range (Markers table) and that the genotype for the con-
trol individual (e.g., 1347-02) matches what is expected
(Markers table).
Exporting genotypes
We designed GeneLink to facilitate the merging of our
genotype data with pedigree and phenotype information
(from either the Pedigrees table or the Trait Score table).
This facilitates exporting data in formats commonly used
in downstream analyses (e.g., GAS or LINKAGE format).
There are three ways data can be exported. First, any user
with administrator (admin) privileges can export data by
Panel in LINKAGE or GAS formats. We use this option
when checking our data for Mendelian inconsistencies
because most laboratory errors could be detected if multi-
ple markers within a panel showed up as inconsistent.
Next, other users with export privileges can export data by
chromosome. All data are exported by chromosome in the
map order specified in the maps table. Chromosomes are
only available for exporting once data for all markers on
that chromosome have been imported, though we did
design GeneLink to accommodate the possibility that all
markers on a chromosome may not have been typed for
all sites. The export genotype data screen (Figure 5), from
the Export by chromosome menu link, prompts users to
specify which chromosome to export, which trait(s) to
export, how to define liability classes if necessary, what
file format is desired and which families to include in the
export. Only the family collection sites to which a user's
group has access will appear in this screen. The final way
data can be exported by users with export  privileges is
directly from the Families table. Using the Export by chro-
mosome option described above means that all families
from the selected site(s) will be exported. Alternatively,
exporting directly from the Families table makes it possi-
ble to export only a subset of families from a collection
site or a subset of families from across sites. Regardless of
the exporting mechanism employed, GeneLink generates
an Export Report, which summarizes all the pertinent
information regarding the export, including families,
chromosome (exported markers and distance between
Liability classes Figure 4
Liability classes Within GeneLink liability classes can be defined using any combination of age, sex, and affection status.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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them), phenotypes included, liability class definition, and
file format (Figure 6). Each export is given a name, which
includes the project ID, chromosome exported, user ID,
and a random number. This naming convention was
designed to facilitate file management.
Results and discussion
When faced with the challenge of studying 496 hereditary
prostate cancer families and a total of 5,247 individuals,
we sought a publicly available database management sys-
tem capable of handling the unique challenges that
accompany a large-scale, multi-center genetic linkage
study of a complex trait. Although data management sys-
tems have been developed [8-12], none could securely
and efficiently handle a very large amount of data, as well
as provide additional features to facilitate quality control
and analysis of data generated. Therefore, we developed
GeneLink, a database with unique features, to address
these needs.
We designed GeneLink to use a Sybase database backend
to take advantage of Sybase's ability to process large
amounts of data. Currently, GeneLink is the only publicly
available freeware database capable of efficiently storing
millions of genotypes. The need for efficient data manage-
ment will grow in importance as researchers explore
Export by chromosome Figure 5
Export by chromosome The Export Genotype Data screen prompts users to specify 1) which chromosome to export, 
2) which trait(s) to export (Status Field), 3) how to define liability classes, 4) what file format is desired and 5) which families to 
include in the export.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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Export report Figure 6
Export report GeneLink's Export Report provides a summary of all pertinent information relating to an export. This 
includes the file name (which incorporates the project ID, chromosome exported, user ID, and a random number), date the 
file was created and by whom. The Export Report also records which chromosome, phenotypes (status field) and families, 
were exported and in what file format. Finally, the Export Report also provides the distance between markers being 
exported.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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genome-wide SNP association studies that may generate
close to one billion genotypes (500 cases, 500 controls
and 500,000 to 1,000,000 SNPs) [13]. We are currently
updating GeneLink so it can run using either Sybase or
Oracle. Furthermore, GeneLink was designed to avoid
database-specific code and therefore should be portable to
other open access DB engines, such as PostgreSQL, with-
out too much difficulty.
To collect the necessary number of DNA samples needed
to provide sufficient power to detect linkage or associa-
tion, collaborative efforts are almost always required. The
Web-based interface of GeneLink facilitates multi-center
collaborations, as data can easily be accessed via the Inter-
net. GeneLink's Web-based interface also makes it
platform-independent, a feature that was essential given
the number of researchers who would be accessing it
using various hardware-browser combinations. Other
publicly-available databases described in the literature do
not have this advantage. In this paper, we have presented
GeneLink in the context of a collaborative effort in which
multiple sites will need access to data generated in a single
laboratory. However, GeneLink would also be valuable in
the context of a meta-analysis of data generated in more
than one laboratory. Making data access easier for our col-
laborators translated into the need for a sophisticated
security system. Specifically, in our study of hereditary
prostate cancer, researchers are permitted access to only
their own set of data. This is important because, in some
cases, a site's internal review board (IRB) protocol may
not allow for raw data to be shared with other analysts.
GeneLink provides several other advantages for investiga-
tors performing linkage or linkage disequilibrium studies
of complex traits. For example, the process by which gen-
otypes can be imported into GeneLink was designed to be
flexible enough to handle data from laboratories like our
own which employ duplicated samples and double-scor-
ing methods for quality control purposes. Using dupli-
cated samples and double scoring aids us in keeping our
genotyping error rate low (< 1%). In our HPC study, we
included 92 duplicated samples (~ 4% of total samples)
in order to evaluate our genotyping error rate. The entire
import process is outlined in Figures 7A and 7B. After each
of the initial steps (the import (step 1), duplicates check
(step 2), and check for differences (step 3)), GeneLink
produces a summary report (Figures 8A,8B, and 8C). The
"Import Report" summarizes the details of the import,
including the date, user ID, number of records imported,
and file name of the uploaded flat file containing the gen-
otype data (Figure 8A). Examples of the duplicates and
differences reports are shown in Figures 8B and 8C.
Another challenge of complex trait linkage or association
studies is formatting data appropriately for analysis by
existing software packages. Chromosome-specific LINK-
AGE, GAS, and RelCheck format files can easily be
exported by GeneLink. By design GeneLink's exporting
capabilities also provide several additional advantages.
First, GeneLink is capable of exporting multiple traits at
the same time, thus facilitating analyses in which covari-
ate information will be included. Second, by taking
advantage of GeneLink's ability to generate liability
classes defined by age, sex, and affection status, research-
ers can maximize power in the investigation of complex
traits, which often exhibit reduced penetrance and phen-
ocopies. Third, GeneLink's Allele Translation table allows
comparison of alleles across families or across analyses, as
each allele for each polymorphic marker will only be
recoded once. This is particularly important as linkage
disequilibrium or association studies become more com-
mon. Fourth, GeneLink's ability to export only a subset of
families is critical, as genetic heterogeneity is a significant
factor contributing to the difficulty of mapping genes
involved in many complex traits. Multiple genes (RNA-
SEL, ELAC2, and MSR1, among others; [14-16]) have
been implicated in hereditary prostate cancer susceptibil-
ity, suggesting that genetic heterogeneity is likely to be a
complicating factor in the gene mapping of HPC risk alle-
les regardless of the analysis method. Finally, GeneLink
maintains a list of previously exported files, which
eliminates redundant generation of data files by collabo-
rators and functions as an archive of data files used for
analyses.
Additional quality control measures were included in
GeneLink's design. First, all changes to the database are
recorded. As genetic studies of complex traits can be
spread over many years, it is important to keep a detailed
log of any changes made to the data. For example, an
individual's affection status may change during the course
of a study; therefore it is critical to track when this infor-
mation was updated in the database. Second, in order to
monitor data quality, GeneLink was also designed to per-
form several built-in checks, as described above.
Given that genetic studies of complex traits will generate
millions (or even billions) of genotypes, it is essential to
have appropriate mechanisms in place to ensure data
integrity. In our study of hereditary prostate cancer, these
checks immediately discovered a typographical error,
which, if left undiscovered, would have resulted in data
from an affected individual never being exported or ana-
lyzed. Finally, GeneLink generates detailed reports storing
pertinent information regarding all imports and exports
(Figures 6 and 8A), the status of projects (Figure 9), statis-
tical information about markers (success rates and heter-
ozygosity; Figure 10A), and DNA samples tested (Figure
10B). These reports are helpful in maintaining data qual-
ity. For example, in our HPC study with over 2,500 DNABMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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A, and B. Import process Figure 7
A, and B. Import process Outline of Import process illustrates GeneLink's ability to be used in laboratories that include 
duplicated samples and double scoring for quality control purposes. Import process includes within table duplicate check and 
across table differences check. Using the Single table import allows the differences step to be skipped.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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A, B, and C. Example of import (A), duplicates (B), and differences (C) reports Figure 8
A, B, and C. Example of import (A), duplicates (B), and differences (C) reports Import report stores all information 
regarding genotypes imported into GeneLink. This information includes number of records imported (how many unique indi-
viduals, how many markers) as well as the name of the file in which records are stored. The duplicates process checks for 
duplicate genotypes within a table. A duplicate is defined as records with the same FamInd ID and marker. All duplicate records 
are reported. If duplicate records have the same two alleles then one record is deleted. If the two duplicate records do not 
have matching alleles than the user is prompted to select which record to delete. The differences process looks for differences 
in genotypes compared across tables (independently scored by two researchers). All differences are reported and the user is 
prompted to resolve each appropriately. The user is given the option to save either record or if either score isn't acceptable 
then new genotype can be indicated.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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samples, it would have been very easy to miss that any sin-
gle individual was failing for greater than 95% of markers
if we were not using GeneLink. We were able to request
new DNA samples for such individuals, as well as flag the
stored data as potentially problematic.
Status report Figure 9
Status report GeneLink's status reports allow collaborators to easily tract the project's progress by site. Reports show 
markers by chromosome (in map order) and the status of each marker for each site. By site, markers can be Not started, In Lab, 
Genotypes Imported, Single Table Imported, Waiting for Comparison, Compared and Ready, Ready to Finalize and Ready to Export. 
Data can be exported only after all markers on a given chromosome for a given site are Ready to Export. In this example we are 
looking at markers D21S1256, D21S1914, D21S1909, D21S1252, D21S2055, D21S266, and D21S1446 on chromosome 21 for 
sites JHU, AAHPC, AAHPC2, Sweden, Finland and Michigan. Here data is ready to export for family sites AAHPC2 and 
Sweden.
A, and B. Marker (A) and individual (B) summaries Figure 10
A, and B. Marker (A) and individual (B) summaries GeneLink's Marker Summary provides success rates and hetero-
zygosity for individual markers typed in the study. The Marker Summary also provides information regarding when the gen-
otype records for this marker were imported (Import Dates). Marker quality can also be evaluated using the Flags column. 
Genotypes can be flagged with a T to temporarily blank scores from analyses. This is used for un-resolvable Mendelian incon-
sistencies. The R flag can be used for replaced DNA samples until the new DNA sample is evaluated. Neither T nor R flagged 
genotypes are exported. Individual summaries also provide global quality assurance information such as success or flag 
rates.BMC Genomics 2004, 5:81 http://www.biomedcentral.com/1471-2164/5/81
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GeneLink was designed primarily in the context of family-
based studies of complex traits. It is capable of handling
both linkage and association data, and can be used for
both whole genome scans and/or candidate-gene studies.
Further development of GeneLink will focus on extending
its capabilities in regard to the case-based design. We rec-
ognize that both the family-based and case-based study
designs have unique advantages, so we see it as critical to
make GeneLink flexible enough to accommodate a case-
based design. Currently, there is no limitation in storing
case-based data however changes to GeneLink's exporting
mechanisms should be made. Finally, in the same way
that GeneLink is capable of storing "exported" data input
files, future work will center on the storage of analysis
results. Again, this would be helpful for multi-center col-
laborative studies, which will continue to be critical to
successful efforts to identify genes important in complex
trait etiology.
Conclusions
In summary, GeneLink was designed specifically to ease
the data management burden of mapping complex traits.
It provides many functions that make it a uniquely
powerful tool for use in genetic linkage or association
studies. GeneLink simplifies merging genotypic data with
pedigree, phenotype, and genetic or physical map infor-
mation. Specifically, GeneLink's design makes it ideal for
large-scale, multi-center studies, which will become more
and more common in efforts to dissect the genetic factors
contributing to complex trait etiology.
Availability and requirements
Project name: GeneLink
Project home page: http://research.nhgri.nih.gov/
genelink
Operating system(s): Platform independent
Programming language: Perl
Other requirements: Sybase SQL server ASE 12.5.1, Perl
version 5.6.1 or greater, CPAN Perl modules DBI,
DBD::Sybase, CGI, and Carp, Web server such as Apache
1.3.29
License: Sybase SQL server ASE 12.5.1
Any restrictions to use by non-academics: none
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